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We read with interest the nice review of Morava et al1 on the
autosomal recessive cutis laxa syndromes. The authors mention the
De Barsy syndrome and state that the genetic background of the De
Barsy syndrome has not yet been identified. However, in the paper by
Kornak et al2 on impaired glycosylation and cutis laxa caused by
mutations in ATP6V0A2 (ATP6V0A2-CDG according to the novel
nomenclature3,4), one of the patients (see patient CoFe in Table 1 of
Kornak et al2) shows the full clinical picture of the De Barsy syndrome,
including cutis laxa, facial dysmorphy, dwarfism, psychomotor retar-
dation, dystonia, congenital hip dysplasia, and corneal dystrophy
necessitating repeated corneal transplantation. These data suggest
that a subgroup of patients with De Barsy syndrome5 belongs to the
spectrum of ATP6V0A2-CDG. Another cause of De Barsy syndrome
has very recently been identified as mutations in PYCR1, coding for
a mitochondrial enzyme involved in proline metabolism.6 Therefore,
we recommend a systematic screen for ATP6V0A2-CDG and for
mutations in PYCR1 in patients with De Barsy syndrome.
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We appreciate the comments1 on our review on autosomal recessive
cutis laxa syndromes,2 especially the novel information on the
Portuguese patient CoFe3 (Table 1, Kornak et al), who was diagnosed
with a combined N- and O-linked glycosylation disorder and
ATP6V0A2-CDG. De Barsy syndrome is a challenging diagnosis,
and has overlapping features with ARCL type 2, including cutis
laxa, short stature, late closure of the fontanel, congenital hip
dysplasia, some aspects of facial dysmorphism and psychomotor
retardation.4 Still, dystonic movements and progressive corneal
abnormalities are highly suggestive of De Barsy syndrome. So far no
cobble-stone-like brain dysgenesis has been observed in De Barsy
syndrome patients. Although the clinical differentiation is not always
straightforward, progeroid features, the presence of pergamen-like
skin and the absence of subcutaneous fat are distinctive.2 Interestingly,
some of the patients, recently reported to have PYCR1mutations, were
previously diagnosed with De Barsy syndrome,5 while other De Barsy
patients were found to not harbour PYCR1 mutations (unreported
data), thus supporting genetic heterogeneity. We would appreciate
further description and photo documentation of this unique patient,
reported by Leao-Teles, as in our own cohort of six patients with De
Barsy syndrome and those studied by Kornak et al (personal
communication) none of the children had either N-linked or
O-linked glycosylation abnormalities, nor mutations in the ATP6V0A2
gene. Eye anomalies are common in N-glycosylation disorders,6 and
strabismus and high myopia have been reported in combined glyco-
sylation disorders.4 The exceptional observation of corneal abnorm-
alities with a movement disorder in association with ATP6V0A2-CDG
indeed widens the range of symptoms evoking glycosylation studies in
patients with cutis laxa.
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